Decoding Circulating Tumor DNA: Analyzing the Technological Advancements and Growth Drivers in the Global Liquid Biopsy Market.
Circulating tumor DNA (ctDNA) is currently the most mature and dominant biomarker segment within the highly dynamic **liquid biopsy market**. CtDNA consists of short fragments of nucleic acid shed into the bloodstream by dying tumor cells. Its significance stems from its ability to carry the same genetic mutations and molecular alterations found in the primary tumor and metastatic sites,...
0 Commentaires
0 Parts
247 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt